53% covid-19 cases from Kerala, Maharashtra
Agencies / Updated: Jul 10, 2021, 06:00 IST
Debunk misplaced beliefs that covid is over: Centre
Maharashtra and Kerala recorded more than half of the covid-19 cases registered in India last week, the Centre said on Friday as it stressed that the pandemic is far from over and there is no room for complacency. In a press conference, a senior official said, “The country is still dealing with the second wave and we need to introspect if we can afford misplaced belief that covid-19 is over.”
The government said visuals from tourist spots and the way people are mingling without following covid protocols is “a serious cause of concern” and that such negligence will increase the risk of virus spread.
Treatment for non-COVID patients takes hit amid focus on pandemic, Delhi hospital study suggests
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Treatment for non-COVID patients takes hit amid focus on pandemic, Delhi hospital study suggests
dtnext.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dtnext.in Daily Mail and Mail on Sunday newspapers.
Treatment for non-Covid patients hit amidst focus on Covid: Study
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.
Chloroquine Nasal drops have potential to prevent covid-19 infection in early stage: AIIMS study ANI | Updated: Jan 21, 2021 14:27 IST
By Priyanka Sharma
New Delhi [India] January 21 (ANI): A study by the doctors of All India Institute of Medical Sciences (AIIMS), New Delhi reveals that Chloroquine (CQN), when administered as nasal drops, has the potential to prevent COVID-19 infection if administered before the infection is established.
The aim of the study was to explore the safety and efficacy of topical nasal administration of CQN drops in reducing viral load and preventing clinical progression in early COVID-19 infection. The present study suggests the potential of topical nasal CQN in the prevention of COVID-19 infection if administered before the infection is established. No significant differences in clinical or virological outcome were, however, demonstrated in patients with mild but established illness, said Dr Alok Thakar, prof